Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VTGN - VistaGen Therapeutics Inc. (VTGN) CEO Shawn Singh on Q1 2022 Results - Earnings Call Transcript

VTGN - VistaGen Therapeutics Inc. (VTGN) CEO Shawn Singh on Q1 2022 Results - Earnings Call Transcript

VistaGen Therapeutics Inc.
VistaGen Therapeutics, Inc. (VTGN) Q1 2022 Earnings Conference Call August 12, 2021 05:00 PM ET Company Participants Mark Flather - Vice President, Investor Relations Shawn Singh - Chief Executive Officer Jerry Dotson - Chief Financial Officer Mark Smith - Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies Presentation Operator Greetings, and welcome to the VistaGen Therapeutics First Quarter 2022 Results Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions]. As a reminder, this conference is being recorded today, Thursday, August 12, 2021. I would now like to turn the conference over to Mr. Mark Flather, Vice President of Investor Relations. Please go ahead, sir. Mark Flather Thank you, Daenerys [ph]. Hello, and welcome to the VistaGen’s conference call covering its fiscal year 2022 first quarter financial results and corporate update. I am Mark Flather, Vice

For further details see:

VistaGen Therapeutics, Inc. (VTGN) CEO Shawn Singh on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com
Menu
VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...